We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GALT icon
14601
CALL
Galectin Therapeutics
GALT
$343M
$339 ﹤0.01%
+300
New +$400
AUMN
14602
PUT
DELISTED
Golden Minerals Company
AUMN
$329 ﹤0.01%
+48
New +$315
CKPT
14603
DELISTED
Checkpoint Therapeutics
CKPT
$327 ﹤0.01%
64
-1,598
-96% -$11.5K
SIEN
14604
PUT
DELISTED
Sientra, Inc.
SIEN
$325 ﹤0.01%
+160
New +$553
KRON
14605
PUT
DELISTED
Kronos Bio
KRON
$324 ﹤0.01%
+200
New +$460
EVLO
14606
PUT
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$322 ﹤0.01%
+10
New +$396
OPTT icon
14607
PUT
Ocean Power Technologies
OPTT
$55.4M
$315 ﹤0.01%
+700
New +$480
FUSN
14608
PUT
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$315 ﹤0.01%
+100
New +$249
GMBL
14609
PUT
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
0
CANO
14610
DELISTED
Cano Health, Inc.
CANO
$314 ﹤0.01%
2
-100
-98% -$33.9K
RMTI icon
14611
PUT
Rockwell Medical
RMTI
$29.6M
$305 ﹤0.01%
+30
New +$321
BLNE
14612
CALL
Beeline Holdings
BLNE
$32.5M
$296 ﹤0.01%
+6
New +$337
PRSO icon
14613
CALL
Peraso
PRSO
$10.2M
$292 ﹤0.01%
+10
New +$528
NCMI icon
14614
CALL
National CineMedia
NCMI
$260M
$286 ﹤0.01%
+130
New +$571
APLT
14615
DELISTED
Applied Therapeutics
APLT
$284 ﹤0.01%
+374
New +$296
HBIO icon
14616
CALL
Harvard Bioscience
HBIO
$30.5M
$277 ﹤0.01%
+10
New +$246
EPHYW
14617
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$277 ﹤0.01%
+120,308
New +$3.33K
VQS
14618
PUT
DELISTED
VIQ SOLUTIONS INC
VQS
$263 ﹤0.01%
+1,000
New +$410
PTN
14619
PUT
Palatin Technologies
PTN
$17.1M
$256 ﹤0.01%
+2
New +$430
CISO
14620
CALL
CISO Global
CISO
$11.7M
$255 ﹤0.01%
+7
New +$318
CALC icon
14621
PUT
CalciMedica
CALC
$19.7M
$250 ﹤0.01%
+36
New +$404
TKC icon
14622
Turkcell
TKC
$4.75B
$249 ﹤0.01%
52
-24,233
-100% -$95.1K
MNTN.WS
14623
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$248 ﹤0.01%
16,438
+2,390
+17% +$89
CAN
14624
Canaan Creative
CAN
$170M
$247 ﹤0.01%
120
-17,494
-99% -$48.4K
SNCR
14625
PUT
DELISTED
Synchronoss Technologies
SNCR
$247 ﹤0.01%
+44
New +$363

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.